Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation
Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation
Recruiting · NCT05509933 · Registry updated 2026-05-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation | engraftment syndrome | Recruiting | Phase 3 | 2026-05-01 | NCT05509933 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Henry Ford Health System | 77 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Henry Ford Health System | Detroit | United States | 147 |